Arbor Pharmaceuticals (“Arbor”), a specialty pharmaceutical company, announced that KKR (NYSE: KKR), a leading global investment firm, is acquiring a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE